Effect of nicotine or cotinine on metabolism of 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver

被引:0
|
作者
Johannes Schulze
Eberhard Schrader
Heidi Foth
Georg F. Kahl
E. Richter
机构
[1] Walther-Straub-Institute of Pharmacology und Toxicology,
[2] Ludwig Maximilians University of München,undefined
[3] Nussbaumstrasse 26,undefined
[4] D-80336 München,undefined
[5] Germany,undefined
[6] Institute of Toxicology,undefined
[7] University of Göttingen,undefined
[8] Robert-Koch-Strasse 40,undefined
[9] D-37075 Göttingen,undefined
[10] Germany,undefined
[11] Institute of Environmental Toxicology,undefined
[12] Martin Luther University Halle-Wittenberg,undefined
[13] Franzosenweg 1a,undefined
[14] D-06097 Halle (Saale),undefined
[15] Germany,undefined
来源
Naunyn-Schmiedeberg's Archives of Pharmacology | 1998年 / 357卷
关键词
Key words NNK; Nicotine; Cotinine; Starvation; Metabolism; Lung; Liver; Perfusion;
D O I
暂无
中图分类号
学科分类号
摘要
The scope of the present study was to investigate whether nicotine or cotinine will affect the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated perfused rat lungs and livers and to study the effect of starvation on pulmonary metabolism of NNK. NNK metabolism was investigated in isolated perfused liver and lung of male F344 rats perfused with 35 nM [5-3H]NNK in presence of a 1400-fold excess of the main tobacco alkaloid nicotine and its metabolite cotinine. In perfused rat livers, nicotine and cotinine inhibited NNK elimination and metabolism and led to a substantial increase of elimination half-life from 14.6 min in controls to 25.5 min after nicotine and 36.6 min after cotinine co-administration, respectively. In parallel, the pattern of NNK metabolites was changed by nicotine and cotinine. The pathway of α-hydroxylation representing the metabolic activation of NNK was decreased to 77% and 85% of control values, whereas N-oxidation of NNK and glucuronidation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was increased 2.6- and 1.2-fold in presence of nicotine and cotinine, respectively. When isolated rat lungs were perfused with 35 nM NNK for 3 h neither the elimination nor the pattern of metabolites were substantially affected due to co-administration of 50 μM nicotine or cotinine. Cytochrome P450 2E1 is known to participate in the activation of NNK and can be induced by starvation. However, isolated rat lungs from male Sprague Dawley rats perfused with [1-14C]NNK at about 2 μM for 3 h, revealed only small differences in pulmonary elimination and pattern of NNK metabolites between fed and starved animals.
引用
收藏
页码:344 / 350
页数:6
相关论文
共 50 条
  • [21] Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in primary cultures of rat alveolar type II cells
    Schrader, E
    Hirsch-Ernst, KI
    Scholz, E
    Kahl, GF
    Foth, H
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (02) : 180 - 185
  • [22] Characterization of human lung enzymes involved in the reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Ashmore, Joseph
    Liu, Ying
    Peterson, Amity
    Fechtner, Sabrina
    Chen, Gang
    Lazarus, Philip
    CANCER RESEARCH, 2015, 75
  • [23] IPOMEANOL ANALOGS AS CHEMOPREVENTIVE AGENTS - EFFECT ON THE IN-VITRO METABOLISM OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE (NNK)
    DESAI, D
    NUNES, M
    CHANG, L
    LIN, JM
    JIAO, D
    AMIN, S
    CANCER LETTERS, 1995, 97 (02) : 155 - 162
  • [24] Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured monkey lung explants
    Hecht, SS
    Trushin, N
    Chhabra, SK
    Anderson, LM
    Nerurkar, PV
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (01) : 5 - 9
  • [25] Identification of 4-(methylnitroamino)-1-(3-pyridyl-1-oxide)-1-butanone, a novel metabolite of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in rat urine
    von Weymarn, Linda
    Dator, Romel
    Balbo, Silvia
    Murphy, Sharon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [26] Absence of metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by flavin-containing monooxygenase (FMO)
    Lamoureux, J
    Castonguay, A
    CARCINOGENESIS, 1997, 18 (10) : 1979 - 1984
  • [27] 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) regulates CTL activation and memory programming
    Sun, Zhifeng
    Xiao, Zhengguo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (03) : 472 - 476
  • [28] Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol
    Atalla, A
    Breyer-Pfaff, U
    Maser, E
    XENOBIOTICA, 2000, 30 (08) : 755 - 769
  • [29] Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
    Ter-Minassian, Monica
    Asomaning, Kofi
    Zhao, Yang
    Chen, Feng
    Su, Li
    Carmella, Steven G.
    Lin, Xihong
    Hecht, Stephen S.
    Christiani, David C.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1338 - 1346
  • [30] Effect of lycopene supplementation on lung carcinogenesis induced by tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in ferrets
    Aizawa, Koichi
    Veeramachaneni, Sudipta
    Liu, Chun
    Smith, Donald
    Ausman, Lynne M.
    Wang, Xiang-Dong
    FASEB JOURNAL, 2013, 27